Alvotech Makes It Four With Denosumab Trial

Study Begins For Firm’s AVT03 Proposed Prolia/Xgeva Biosimilar

 
• By David Wallace
Number 4 Four Pool Ball Cue
Alvotech is cueing up a fourth biosimilar clinical trial program • Source: Shutterstock

More from Biosimilars

More from Products